logo

Yumanity Therapeutics, Inc. (YMTX)



Trade YMTX now with
  Date
  Headline
11/14/2022 8:27:02 AM Yumanity Therapeutics Q3 Net Loss $3.4 Mln Or $0.31/shr Vs Net Loss $10.0 Mln Or $0.97/shr Prior Year
6/6/2022 6:52:38 AM Kineta To Merge With Yumanity In All-stock Transaction
8/16/2021 7:20:42 AM Yumanity Therapeutics Appoints Michael Wyzga As SVP, CFO
3/9/2018 6:26:04 AM RBC Capital Markets Initiates Proteostasis Therapeutics, Inc. (PTI) At Outperform With $11 Price Target
9/12/2016 7:36:10 AM RBC Capital Markets Is Raising Proteostasis Therapeutics, Inc. (PTI) 4Q16 Estimate To -0.46 From -0.60
9/12/2016 7:35:55 AM RBC Capital Markets Is Raising Proteostasis Therapeutics, Inc. (PTI) 3Q16 Estimate To -0.42 From -0.52
9/12/2016 7:35:32 AM RBC Capital Markets Is Increasing Proteostasis Therapeutics, Inc. (PTI) 2017 Estimate To -2.06 From -2.52
9/12/2016 7:35:17 AM RBC Capital Markets Is Increasing Proteostasis Therapeutics, Inc. (PTI) 2016 Estimate To -2.02 From -2.47
9/12/2016 7:35:02 AM RBC Capital Markets Is Cutting Proteostasis Therapeutics, Inc. (PTI) 2017 Rev. Estimate To 6.9 M From 7.5 M
9/12/2016 7:34:44 AM RBC Capital Markets Is Cutting Proteostasis Therapeutics, Inc. (PTI) 2016 Rev. Estimate To 5.5 M From 5.6 M
3/7/2016 7:48:14 AM RBC Capital Markets Initiates Proteostasis Therapeutics, Inc. (PTI) At Outperform With $20 Price Target
1/28/2009 8:43:17 AM KeyBanc Capital Markets Is Cutting Patni Computer Systems (PTI) 2009 Estimate To 1.00 From 1.05
1/28/2009 8:12:12 AM KeyBanc Capital Markets Raises Patni Computer Systems (PTI) To Buy From Hold With $10 Price Target